What Is CBG? The Complete Wholesale Guide for B2B Buyers

CBG (cannabigerol) is a non-intoxicating cannabinoid produced naturally in the hemp plant, and the biosynthetic precursor from which CBD, THC, and CBC all develop as the plant matures. For B2B buyers, CBG represents one of the most significant category opportunities in the post-Section 781 hemp market — a cannabinoid with genuine formulation utility, a growing commercial supply chain, and a price premium that reflects real production constraints rather than marketing inflation. At BCD, we have carried CBG isolate, distillate, flower, and oil since our founding in 2021, and the buyers who are building CBG-based product lines now are constructing supply chains ahead of the market shift toward non-intoxicating cannabinoids.

What CBG Is and How It Forms

CBG begins as CBGA (cannabigerolic acid), the primary precursor cannabinoid synthesized early in the hemp plant’s growth cycle. As the plant matures, enzymatic processes convert the majority of CBGA into CBDA, THCA, and CBCA — the acidic precursors of CBD, THC, and CBC respectively. In a standard CBD-dominant hemp cultivar, this conversion is nearly complete by harvest, leaving only trace CBG in the final plant material (typically 0.5% to 1% by dry weight).

The commercial CBG market was made possible by the development of CBG-dominant hemp genetics, where the enzymatic conversion from CBGA to other cannabinoids is intentionally limited. These specialized cultivars hold 12% to 20% CBG at harvest rather than the sub-1% levels found in standard CBD hemp, making extraction economically viable at commercial scale. The genetics work required to develop stable CBG-dominant varieties is a real cost that is reflected in CBG’s price premium over CBD — it is not markup on a commodity.

CBG Product Forms Available for Wholesale

CBG is available in the same refined forms as CBD, each appropriate for different formulation and application contexts:

CBG isolate: Cannabigerol refined to 99% or higher purity, with all other plant compounds removed. The most precise form for dose-controlled formulations. CBG isolate has a white crystalline appearance similar to CBD isolate but with some important handling differences covered below.

CBG distillate: A concentrated CBG extract typically containing 70% to 90% cannabigerol, with the balance composed of minor cannabinoids and terpenes retained through the distillation process. More cost-effective than isolate for formulations that do not require single-cannabinoid precision. CBG distillate runs 2x to 5x the per-gram cost of comparable CBD distillate.

CBG flower: Hemp flower from CBG-dominant cultivars, dried and prepared for retail smokable formats or as extraction feedstock. CBG flower requires careful harvest timing because CBG content peaks earlier in the plant’s development than CBD in standard cultivars.

CBG oil: CBG in a carrier oil solution, typically MCT or hemp seed oil, at a standardized concentration. Used in tincture and softgel formulations where a pre-diluted, oil-phase CBG ingredient is operationally convenient.

CBG vs. CBD: The Key Differences for Formulators

CBG and CBD are structurally similar cannabinoids with some meaningful differences in behavior and formulation economics. Understanding these differences helps a formulator decide where CBG earns its cost premium and where CBD remains the more sensible choice.

Price: CBG consistently commands a 2x to 5x premium over equivalent CBD forms. This reflects the higher cost of CBG-dominant genetics, the smaller supply base, and the lower cannabinoid yield per kg of input biomass relative to CBD-optimized cultivars. A CBG addition to a formulation needs a product story that justifies the cost differential.

Crystallization: CBG isolate and distillate are more prone to crystallization and solidification at room temperature than their CBD equivalents. This affects storage, handling, and filling equipment operation — particularly for liquid-format products like tinctures and softgels where crystallized ingredient causes processing problems. BCD makes sure buyers understand this property before their first CBG isolate order ships.

Formulation rationale: The most defensible CBG formulations are those where the cannabinoid plays a specific role in the product story — skincare lines where CBG’s profile is a stated ingredient, combination cannabinoid tinctures where CBG contributes to the full-spectrum character, or precisely dosed capsule formats. CBG added at trace levels without a product narrative is cost without story. The same sourcing discipline that applies to CBD applies to CBG, plus the additional supply chain considerations that come with a smaller, less commoditized market.

Applications by Product Category

CBG has established a presence across several product categories where its properties justify the cost premium:

Skincare and topicals: CBG is one of the more active minor cannabinoids in topical formulation contexts, and brands building ingredient stories around multi-cannabinoid profiles are including it in face oils, serums, and targeted topicals. The oil-phase compatibility of CBG distillate and isolate makes it straightforward to incorporate into most topical formulation systems.

Tinctures and sublingual formats: CBG is commonly added to CBD-dominant tinctures at 5 mg to 20 mg per serving to create a multi-cannabinoid formulation. The addition changes the product’s full-panel COA in a way that can be featured on labeling and in marketing, which is where the brand value originates.

Capsules and softgels: The precision dosing possible with CBG isolate makes it well-suited for encapsulated formats. The crystallization management requirement is easier to address in a solid-format product than in a liquid one, making capsules a natural fit for CBG isolate incorporation.

Specialized applications: CBG has attracted research interest in specific niche applications. Buyers in this segment are typically research-stage formulators with specific purity and documentation requirements that align well with BCD’s COA standard.

CBG Pricing: What the Premium Reflects

CBG commands a per-gram price premium of 2x to 5x over equivalent CBD forms across all product types. Understanding where this premium originates helps buyers evaluate whether a given price quote represents fair market value or unusual markup in either direction.

The premium has three roots: genetics (CBG-dominant cultivars require specialized breeding and ongoing seed stock management), yield (CBG-dominant hemp produces fewer total cannabinoid grams per acre than optimized CBD cultivars), and scale (the CBG extraction and processing infrastructure is smaller than the CBD infrastructure, meaning economies of scale are less developed). All three factors are real and ongoing, not transitional. The CBG premium is unlikely to reach CBD price levels within the near-term commercial horizon.

What to Look for in a Wholesale CBG Supplier

The supplier evaluation framework for CBG is similar to CBD with additional attention on three points:

Genetics transparency: A CBG supplier who can describe the cultivar genetics behind their flower or biomass source material is one who understands their supply chain. Ask which CBG-dominant genetics were used and whether the source farm uses stable seed stock. This affects lot-to-lot consistency and your ability to reorder reliably.

Crystallization management: Ask directly how the supplier stores and ships CBG isolate and whether they have observed crystallization in finished lots. A supplier who has not encountered this property in their CBG isolate is either new to the product or not paying attention to how their customers use it.

Lot-specific COA with minor cannabinoid panel: CBG lots from different genetics and harvest timings will carry different residual CBD percentages in the distillate. For formulations where CBG purity matters, confirm the minor cannabinoid breakdown on the specific lot being purchased. BCD provides full minor cannabinoid panel data on all CBG products.

Section 781 and CBG

CBG is a non-intoxicating cannabinoid unaffected by Section 781 of P.L. 119-37 (effective November 12, 2026). The restrictions in Section 781 apply to intoxicating hemp cannabinoids; CBG does not fall into that category. Brands building on CBG-based formulations are building supply chains that remain fully viable after November. BCD’s CBG catalog is a core part of our long-term product strategy precisely because of this regulatory positioning. For a full breakdown of which cannabinoids are affected by Section 781 and which are not, see our 2026 hemp law guide.

Frequently Asked Questions

What is CBG?

CBG (cannabigerol) is a non-intoxicating cannabinoid found in hemp that serves as the biosynthetic precursor to CBD, THC, and CBC. In standard hemp cultivars, most CBG converts to other cannabinoids before harvest, leaving trace amounts. CBG-dominant hemp genetics developed over the past several years hold 12% to 20% CBG at harvest, making commercial extraction economically viable.

What forms of CBG are available for wholesale purchase?

CBG is available as isolate (99%+ purity), distillate (70% to 90% CBG), flower (from CBG-dominant cultivars), and carrier oil solutions. Each form is appropriate for different formulation and application contexts. BCD carries all four forms with lot-specific COA documentation.

Why does CBG cost more than CBD?

CBG commands a 2x to 5x premium over equivalent CBD forms because of three underlying supply constraints: CBG-dominant hemp genetics are specialized and expensive to develop and maintain, yield per acre is lower than CBD-optimized cultivars, and the processing infrastructure is smaller with less developed economies of scale. These are structural factors, not transitional ones.

What is the typical CBG potency in wholesale CBG isolate?

Quality wholesale CBG isolate carries 99% or higher cannabigerol purity by weight. The minor cannabinoid balance (typically residual CBD) should be detailed on the lot-specific COA. For formulations requiring single-cannabinoid precision, confirm the full minor cannabinoid panel before accepting a lot.

Is CBG compliant under Section 781 of P.L. 119-37?

Yes. CBG is a non-intoxicating cannabinoid and is not affected by Section 781 of P.L. 119-37, effective November 12, 2026. The restrictions in Section 781 apply to intoxicating cannabinoids; CBG-based product lines remain fully viable under the post-November federal hemp framework.

What is the MOQ for wholesale CBG from BCD?

MOQs for CBG products at BCD start at 100g to 1 kg depending on the specific product form. Contact BCD to discuss current lot availability, potency specs, and volume pricing for your requirements.

Does CBG isolate crystallize?

Yes. CBG isolate and distillate are more prone to crystallization at room temperature than their CBD equivalents. This is a physical property of the molecule, not a quality defect. Managing it requires appropriate storage conditions and, for liquid-format products, temperature control during production. BCD discusses this property with every new CBG buyer before their first order ships.

What applications is CBG commonly used in?

CBG is used in skincare and topicals, multi-cannabinoid tinctures and sublingual formats, encapsulated products, and specialized applications. The most defensible CBG formulations are those where the cannabinoid plays a specific, stated role in the product story rather than appearing at trace levels without narrative.

How do I evaluate a wholesale CBG supplier?

The key evaluation criteria for a CBG supplier are: genetics transparency (can they describe the source cultivar?), understanding of crystallization behavior (have they addressed it with other customers?), and lot-specific COA with full minor cannabinoid panel. A CBG supplier who cannot address these points has limited direct experience with the product.

What is the difference between CBG and CBD in formulation?

CBG and CBD are structurally related cannabinoids with some meaningful differences: CBG costs 2x to 5x more per gram, is more prone to crystallization, and requires a specific product narrative to justify its inclusion. CBD is the established, lower-cost baseline for most multi-cannabinoid formulations; CBG adds a differentiation layer where the product story supports the cost premium.